[Prevalence of allergic rhinitis in Chinese children from 2001 to 2021: Meta analysis]

R K Wang1, J Q Liang1, W Han2

  • 1Otolaryngology-Head and Neck Surgery, Children's Hospital Capital Institute of Pediatrics, Beijing 100020, China.

Insights

The prevalence of allergic rhinitis in Chinese children is 18.46%, with higher rates observed in recent years (2012-2021) and in specific regions and demographics. This study provides crucial data for understanding and managing allergic rhinitis in children.

Area of Science:

  • Pediatric Allergy and Immunology
  • Epidemiology
  • Public Health

Background:

  • Allergic rhinitis is a common condition affecting children globally.
  • Understanding the epidemiological trends of allergic rhinitis in China is crucial for public health initiatives.
  • Previous data on the prevalence of allergic rhinitis in Chinese children over a two-decade period is limited.

Purpose of the Study:

  • To determine the prevalence of allergic rhinitis in Chinese children from 2001 to 2021.
  • To analyze trends and variations in prevalence based on publication year, geographical region, sex, and ethnicity.
  • To provide essential data for the prevention and treatment strategies for allergic rhinitis in pediatric populations.

Main Methods:

  • Systematic literature search of multiple databases (CNKI, CBM, VIP, WanFang Data, PubMed, Web of Science, Embase, Cochrane Library) for studies published between 2001 and 2021.
  • Inclusion of 20 cross-sectional studies encompassing 54,886 children and adolescents.
  • Meta-analysis performed using Stata 16.0, with subgroup analyses conducted for temporal, regional, sex, and ethnic variations.

Main Results:

  • The overall prevalence of allergic rhinitis among Chinese children was found to be 18.46%.
  • Prevalence increased significantly from 14.81% (2001-2011) to 19.75% (2012-2021).
  • Significant regional variations were observed, with East China showing the highest prevalence (22.77%). Males (20.73%) had a higher prevalence than females (16.34%), and Han Chinese (17.31%) had higher prevalence than ethnic minorities (15.93%).

Conclusions:

  • Allergic rhinitis is highly prevalent in Chinese children.
  • The prevalence of allergic rhinitis in this population has shown an increasing trend.
  • Significant disparities in prevalence exist across different regions, sexes, and ethnic groups, necessitating targeted interventions.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
28.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
560
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
431